Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

NCT05175430 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Paroxetine
DRUG: Lysergic Acid Diethylamide
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland